Sonoma Pharmaceuticals Q4 EPS $(0.07) Up From $(0.31) YoY, Sales $3.44M Miss $3.98M Estimate
Sonoma Pharmaceuticals Q4 EPS $(0.07) Up From $(0.31) YoY, Sales $3.44M Miss $3.98M Estimate
Sonoma pharmaceuticals第四季度每股收益为$(0.07)，同比从$(0.31)上升，销售额为$3.44M，低于$3.98M的预期。
Sonoma Pharmaceuticals (NASDAQ:SNOA) reported quarterly losses of $(0.07) per share. This is a 77.42 percent increase over losses of $(0.31) per share from the same period last year. The company reported quarterly sales of $3.44 million which missed the analyst consensus estimate of $3.98 million by 13.59 percent. This is a 14.10 percent increase over sales of $3.01 million the same period last year.
sonoma pharmaceuticals（纳斯达克：SNOA）报告每股亏损$（0.07），同比去年同期亏损$（0.31）的77.42％。公司报告季度销售额为344万美元，较分析师平均估计的398万美元低13.59％。这是公司去年同期301万美元销售额的增长14.10％。